Hybrid coronary revascularization is offered as an alternative strategy for patients with multivessel coronary artery disease (CAD). We present our experience and provide a comparative analysis to off-pump coronary artery bypass grafting (OPCAB).
Methods
Ninety-one patients with multivessel CAD underwent minimally invasive left internal mammary artery to left anterior descending grafting in combination with percutaneous coronary intervention of nonleft anterior descending targets (HYBRID). The primary end point of this study was major adverse cardiac and cerebrovascular events (MACCE), defined as death, stroke, and nonfatal myocardial infarction. MACCE in the HYBRID group were compared with 4175 contemporaneously performed OPCAB operations by logistic (30-day outcomes) and Cox proportional hazards (long-term survival) regression methods. Propensity scoring was used to adjust for potential selection bias.
Results
The 30-day MACCE (death/stroke/nonfatal myocardial infarction) rate was 1.1% for the HYBRID group (0%/0%/1.1%) and 3.0% for the OPCAB group (1.8%/1.1%/0.5%) (odds ratio = 0.47, P = 0.48). Angiographic left internal mammary artery evaluation was obtained in 95.6% of patients (87 of 91) revealing FitzGibbon A patency in 98.0% (96 of 98). The reintervention rate at 1 year for the HYBRID group was 5.5% (5 of 91) and was limited to repeat percutaneous coronary intervention. Three-year survival was statistically similar for the two groups (hazard ratio = 0.44, P = 0.18, see Kaplan-Meier figure).
Conclusions
Hybrid coronary revascularization may be noninferior to OPCAB with respect to early MACCE and 3-year survival in the treatment of multivessel CAD.
MurphyG.J., BryanA.J., AngeliniG.D.Hybrid coronary revascularization in the era of drug-eluting stents. Ann Thorac Surg.2004; 78: 1861–1867.
2.
AngeliniG.D., WildeP., SalernoT.A.Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet.1996; 347: 757–758.
3.
ZenatiM., CohenH.A., GriffithB.P.Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Surg.1999; 117: 439–444.
4.
WittwerT., CremerJ., BoonstraP.Myocardial “hybrid” revascularization with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty: preliminary results of a multicentre study. Heart.2000; 83: 58–63.
5.
PresbiteroP., NicoliniF., MaielloL.“Hybrid” percutaneous and surgical coronary revascularization: selection criteria from a single center experience. Ital Heart J.2001; 2: 363–368.
6.
CisowskiaM., Morawskia, DrzewieckibJ.Integrated minimally invasive direct coronary artery bypass and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg.2002; 22: 261–265.
7.
RiessF.C., BaderR., KremerP.Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up. Ann Thorac Surg.2002; 73: 1849–1855.
8.
StahlK.D., BoydW.D., VassiliadesT.A., KaramanoukianH.L.Hybrid robotic coronary artery surgery and angioplasty in multi-vessel disease. Ann Thorac Surg.2002; 74: S1358–S1362.
9.
DavidaviciusG., Van PraetF., MansourS.Hybrid revascularization strategy: a pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional flow reserve-guided percutaneous coronary intervention. Circulation.2005; 112(suppl I): I317–I327.
10.
KatzM.R., Van PraetF., de CanniereD.Integrated coronary revascularization percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass. Circulation.2006; 114(suppl I): I473–I476.
11.
VassiliadesT.A.Jr., DouglasJ.S., MorrisD.C.Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome. J Thorac Cardiovasc Surg.2006; 131: 956–962.
KiaiiB., McClureR.S., RaymanR.A novel approach to integrated coronary artery revascularization using bivalirudin. J Thorac Cardiovasc Surg.2008; 136: 702–708.
15.
MosesJ.W., LeonM.B., PopmaJ.J.; SIRIUS Investigators. Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med.2003; 349: 1315–1323.
16.
IndolfiC., PaviaM., AngelilloI.F.Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). Am J Cardiol.2005; 95: 1146–1152.
VassiliadesT.A.Multivessel, all-arterial, off-pump surgical revascularization without disruption of the thoracic skeleton. Ann Thorac Surg.2004; 78: 1441–1445.
D'AgostinoR.B.Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med.1998; 17: 2265–2281.
22.
PageW.F., MahanC.M., KangH.K.Vital status ascertainment through the files of the department of veterans affairs and the social security administration. Ann Epidemiol.1996; 6: 102–109.
23.
LittleR.J., RubinD.B.Statistical Analysis with Missing Data.Wiley: New York; 1987.
24.
FitzgibbonG.M., BurtonJ.R., LeachA.J.Coronary bypass graft fate. Angiographic grading of 1,400 consecutive grafts early after operation and of 1,132 after one year. Circulation.1978; 57: 1070–1074.
25.
LewisB.S., PoratE., HalonD.A.Same-day combined coronary angioplasty and minimally invasive coronary surgery. Am J Cardiol.1999; 84: 1246–1247.
26.
KiaiiB., McClureR.S., KostukW.J.Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest.2005; 126: 4046–4048.
27.
BonattiJ., SchachnerT., BonarosN.Robotic totally endoscopic coronary artery bypass and catheter based coronary intervention in one operative session. Ann Thorac Surg.2005; 79: 2138–2141.
28.
DunningJ., VersteeghM., FabbriA.Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg.2008; 34: 73–92.
29.
MaltaisS., PerraultL.P., DoQ.B.Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur J Cardiothorac Surg.2008; 34: 127–131.
30.
KelleyM.P., KlugherzB.D., HashemiS.M.One-year clinical outcomes of protected and unprotected left main coronary artery stenting. Eur Heart J.2003; 24: 1554–1559.
31.
WoodF., BazemoreE., SchneiderJ.E.Technique of left main stenting is dependent on lesion location and distal branch protection. Catheter Cardiovasc Interv.2005; 65: 499–503.
32.
LoickH.M., ScheldH.H., Van AkenH.Impact of perioperative transesophageal echocardiography on cardiac surgery. Thorac Cardiovasc Surg.1997; 45: 321–325.
33.
GurbelP.A., BlidenK.P., EtheringtonA., TantryU.S.Assessment of clopidogrel responsiveness: measurements of maximum platelet aggregation, final platelet aggregation and their correlation with vasodilatorstimulated phosphoprotein in resistant patients. Thromb Res.2007; 121: 107–115.
34.
FilsoufiF., RahmanianP.B., CastilloJ.G.Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements. J Cardiothorac Vasc Anesth.2008; 22: 60–66.
35.
SerruysP.W., MoriceM.C.Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med.2009; 360: 961–972.
36.
Data presented at TCT 2008.Transcatheter Cardiovascular Therapeutics 20th Annual Scientific Symposium, Washington, DC, October 16, 2008.
37.
DaemenJ., BoersmaE., FlatherM.Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation.2008; 118: 1146–1154.
38.
BakhaiA., HillR.A., DundarY.Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. Cochrane Database Syst Rev.2005: CD004588.
39.
TakagiH., KawaiN., UmemotoT.Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease. Am J Cardiol.2008; 101: 1259–1262.
